|
Sep 30
|
Will Ovid Therapeutics (NASDAQ:OVID) Spend Its Cash Wisely?
|
|
Sep 26
|
Ovid Therapeutics Presents Pre-Clinical Study Results Demonstrating OV329 Does Not Accumulate in Animal Eyes in Contrast with Vigabatrin
|
|
Jul 30
|
Ovid Therapeutics to Present at Upcoming August Investor Conferences
|
|
Jul 23
|
Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and Epileptologists
|
|
Jun 20
|
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
|
|
Jun 18
|
OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies
|
|
Jun 18
|
Apple downgraded, Kroger upgraded: Wall Street's top analyst calls
|
|
May 14
|
Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 14
|
Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial Results
|
|
May 13
|
Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference
|
|
May 1
|
Beam Therapeutics Inc. (BEAM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Apr 26
|
Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Apr 18
|
We Think Ovid Therapeutics (NASDAQ:OVID) Can Afford To Drive Business Growth
|
|
Apr 4
|
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 22
|
Ovid Therapeutics Reaches US$197m Market Cap Benefiting Insider Stock Buying
|
|
Mar 8
|
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results
|
|
Feb 28
|
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
|
|
Feb 6
|
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
|
Dec 1
|
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)
|
|
Sep 29
|
20 Countries With Highest Rate of Epilepsy
|